Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Parallel-Group Study of the Relationship Between Kidney Injury Severity and Severity of COVID-19

NCT04386564 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.

NCT NCT04386564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04386564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Parallel-Group Study of the Relationship Between Kidney Injury Severity and Severity of COVID-19
Lead sponsor
I.M. Sechenov First Moscow State Medical University
Phase
Observational
Overall status
Completed
Start date
May 15, 2020
Completion date
September 1, 2020
Enrollment
340 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, kidney injury